Center-Authored Papers

Filters: Author is Wolchok, Jedd D  [Clear All Filters]
C
Carvajal RD, Wong MK, Thompson JA, Gordon MS, Lewis KD, Pavlick AC, Wolchok JD, Rojas PB, Schwartz JD, Bedikian AY.  2014.  A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma.. European journal of cancer (Oxford, England : 1990). Abstract
Chapuis AG, Roberts IM, Thompson JA, Margolin KA, Bhatia S, Lee SM, Sloan HL, Lai IP, Farrar EA, Wagener F et al..  2016.  T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(31):3787-3795. Abstract
Chapuis AG, Lee SM, Thompson JA, Roberts IM, Margolin KA, Bhatia S, Sloan HL, Lai I, Wagener F, Shibuya K et al..  2016.  Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.. The Journal of experimental medicine. 213(7):1133-9. Abstract
L
Lesokhin A, Hohl TM, Kitano S, Cortez C, Hirschhorn-Cymerman D, Avogadri F, Rizzuto GA, Lazarus JJ, Pamer EG, Houghton AN et al..  2012.  Monocytic CCR2+ Myeloid Derived Suppressor Cells Promote Immune Escape By Limiting Activated CD8 T Cell Infiltration Into The Tumor Microenvironment.. Cancer research. 72(4):876-886. Abstract
M
McDermott D, Lebbé C, Hodi SF, Maio M, Weber JS, Wolchok JD, Thompson JA, Balch CM.  2014.  Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma.. Cancer treatment reviews. Abstract
P
Page DB, Yuan J, Redmond D, Wen HY, Durack JC, Emerson R, Solomon SB, Dong Z, Wong P, Comstock C et al..  2016.  Deep Sequencing of T-Cell Receptor DNA as a biomarker of clonally expanded TILs in breast cancer after immunotherapy.. Cancer immunology research. 4(10):835-844. Abstract
S
Schadendorf D, Hodi SF, Robert C, Weber JS, Margolin K, Hamid O, Patt D, Chen T-T, Berman DM, Wolchok JD.  2015.  Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Y
Yee C.  2007.  Adoptive Cellular Therapy of Cancer. General Principles of Tumor Immunotherapy Basic and Clinical Applications of Tumor Immunology. :343-361.